Published in J Rheumatol on August 01, 1995
Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45
Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol (2002) 1.93
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci U S A (2002) 1.65
Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.28
Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis (2006) 1.25
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica (Cairo) (2013) 1.20
Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells. Proc Natl Acad Sci U S A (2012) 1.18
Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.11
Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Res Ther (2004) 1.04
IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One (2006) 0.95
Bone invading NSCLC cells produce IL-7: mice model and human histologic data. BMC Cancer (2010) 0.90
Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res Ther (2012) 0.88
T-cells and B-cells in osteoporosis. Curr Opin Endocrinol Diabetes Obes (2014) 0.84
Differentiation of naive CD4+ T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients. Arthritis Res Ther (2003) 0.81
Interleukin-7 and Toll-like receptor 7 induce synergistic B cell and T cell activation. PLoS One (2014) 0.79
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal Biochem (1981) 6.45
Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum (1997) 5.57
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med (1994) 3.61
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A (2000) 3.37
Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum (1991) 2.91
Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol (2001) 2.85
Communication about sexual issues: mothers, fathers, and friends. J Adolesc Health (1999) 2.80
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol (1999) 2.78
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol (1993) 2.56
Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol (2001) 2.55
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol Microbiol (1998) 2.33
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol (2000) 2.19
ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem (1997) 2.15
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med (2000) 2.10
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother (1996) 1.88
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.69
P2X7-related modulation of pathological nociception in rats. Neuroscience (2007) 1.67
Localization of Usher syndrome type II to chromosome 1q. Genomics (1990) 1.67
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55
Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol (1996) 1.55
Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest (1994) 1.53
Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res (2001) 1.52
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci (2006) 1.52
Methotrexate in juvenile idiopathic arthritis: answers and questions. J Rheumatol (2000) 1.51
Antiphospholipid antibodies in paediatrics. Eur J Pediatr (1994) 1.46
Interaction of interferon with cellular receptors. Internalization and degradation of cell-bound interferon. J Biol Chem (1982) 1.46
Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report. Angiology (1998) 1.45
Three newly delimited species of Saccharomyces sensu stricto. Antonie Van Leeuwenhoek (1987) 1.43
The Federated Council of Internal Medicine's resource guide for residency education: an instrument for curricular change. Ann Intern Med (1997) 1.43
Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient. Leukemia (1991) 1.41
Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry (1999) 1.40
Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases. J Immunol (1994) 1.39
Vertebral and carotid artery dissection following chiropractic cervical manipulation. Neurosurg Rev (1999) 1.38
Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med (1995) 1.36
Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol (2004) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol (1997) 1.32
Pilon fractures: treatment with combined internal and external fixation. J Orthop Trauma (1993) 1.32
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
Different mechanisms for activation of gene transcription by interferons alpha and gamma. Virology (1985) 1.29
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29
[Leishmania tropica in Morocco. III--The vector of Phlebotomus sergenti. Apropos of 89 isolates]. Ann Parasitol Hum Comp (1991) 1.27
Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis (1995) 1.25
Diabetes, cardiovascular risk factors and idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurootol (2009) 1.24
Immune-mediated inner ear disease. Acta Otolaryngol (2006) 1.23
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr (1996) 1.23
Facts, myths and legends on the prime industrial microorganism. J Ind Microbiol (1995) 1.22
Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol (1997) 1.21
Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor. Cancer Res (1996) 1.21
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum (2008) 1.20
The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies. Clin Pharmacol Ther (1976) 1.17
Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol (1993) 1.16
Systematic review of the literature on the clinical effectiveness of the cochlear implant procedure in paediatric patients. Acta Otorhinolaryngol Ital (2011) 1.16
Copolymers of chondroitin 4-sulfate and chondroitin 6-sulfate in chick embryo epiphyses and other cartilage. J Biol Chem (1978) 1.15
Characterization of osteoclast precursors in human blood. Br J Haematol (2000) 1.14
Gene mapping of Usher syndrome type IIa: localization of the gene to a 2.1-cM segment on chromosome 1q41. Am J Hum Genet (1995) 1.14
Survival after in-hospital cardiopulmonary arrest of noncritically ill patients. A prospective study. Chest (1994) 1.14
[Leishmania tropica in Morocco. IV--Intrafocal enzyme diversity]. Ann Parasitol Hum Comp (1991) 1.14
Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer (1994) 1.13
Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas. J Clin Microbiol (1999) 1.13
Auditory and academic performance of children with unilateral hearing loss. Scand Audiol Suppl (1988) 1.13
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis (1998) 1.12
Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. J Pediatr (1998) 1.12
Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience. Mod Pathol (1993) 1.12
Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers. Br J Clin Pharmacol (1981) 1.11
Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol (1993) 1.11
The endoplasmic reticulum-sarcoplasmic reticulum connection: distribution of endoplasmic reticulum markers in the sarcoplasmic reticulum of skeletal muscle fibers. Proc Natl Acad Sci U S A (1992) 1.10
Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis (1997) 1.10
Multiple binding sites in fibronectin and the staphylococcal fibronectin receptor. Eur J Biochem (1992) 1.09
Psychological profile and social behaviour of working adults with mild or moderate hearing loss. Acta Otorhinolaryngol Ital (2008) 1.09
PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis (2005) 1.09
Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg (1999) 1.08
Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. Cancer Treat Rep (1982) 1.08
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am J Hum Genet (1990) 1.08
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J (2007) 1.08
Electrophoretic karyotyping as a taxonomic tool in the genus Saccharomyces. Antonie Van Leeuwenhoek (1993) 1.08
Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr (1987) 1.07
Characterization of an interferon receptor on human lymphoblastoid cells. Proc Natl Acad Sci U S A (1983) 1.07
Binding of human recombinant 125I-interferon gamma to receptors on human cells. J Biol Chem (1985) 1.07
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem (1999) 1.07
Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum (2011) 1.06
Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol (1990) 1.06
Preliminary phase I study of 4'-epi-adriamycin. Cancer Treat Rep (1979) 1.06
An intensive care unit nurse with a recurring annular lesion. Erythema annulare centrifugum (EAC). Arch Dermatol (1992) 1.06
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens. J Pharm Sci (1974) 1.05
Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) (2006) 1.05
Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol (1999) 1.04
Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage. J Immunol (1992) 1.03
Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res (1998) 1.03
Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann Rheum Dis (1991) 1.03
Focusing forward genetics: a tripartite ENU screen for neurodevelopmental mutations in the mouse. Genetics (2011) 1.02